工艺研发
ENGLISH ABSTRACT
基于MDCK细胞培养的B型流感病毒液的超滤浓缩工艺研究
吴熠潇
刘海东
朱绍荣
作者及单位信息
·
DOI: 10.3760/cma.j.cn311962-20240730-00052
Study on ultrafiltration concentration process of influenza B virus liquid based on MDCK cell culture
Wu Yixiao
Liu Haidong
Zhu Shaorong
Authors Info & Affiliations
Wu Yixiao
R&D Center,Shanghai Rongsheng Biotechnology Co.,Ltd.,Shanghai 201108,China
Liu Haidong
R&D Center,Shanghai Rongsheng Biotechnology Co.,Ltd.,Shanghai 201108,China
Zhu Shaorong
R&D Center,Shanghai Rongsheng Biotechnology Co.,Ltd.,Shanghai 201108,China
·
DOI: 10.3760/cma.j.cn311962-20240730-00052
19
7
0
0
0
0
PDF下载
APP内阅读
摘要

目的研究在不同工艺参数下,使用超滤膜包和中空纤维柱超滤浓缩基于MDCK细胞培养的B型流感病毒液的效果。

方法制备6批次基于MDCK细胞培养的B型流感病毒澄清液,采用超滤膜包和中空纤维柱对B型流感病毒澄清液2倍浓缩后洗滤。取鸡红细胞悬液检测病毒浓缩液的血凝滴度,使用Lowry法2测定蛋白含量并计算抗原回收率和杂蛋白去除率,以考察不同洗滤次数和超滤膜类型对以上指标的影响;对洗滤10次的病毒洗滤液进行超滤浓缩,分析使用2种超滤膜超滤浓缩后不同膜清洗次数下的病毒残留情况;评价病毒浓缩液在不同保存温度下的稳定性。

结果超滤膜包和中空纤维柱洗滤后,病毒洗滤液的血凝滴度保持稳定,洗滤次数为5次时,杂蛋白去除率较高,达到90%以上。中空纤维柱处理后的病毒浓缩液抗原回收率(61.95%)略高于超滤膜包(49.91%),2种超滤膜处理后收获的病毒浓缩液杂蛋白去除率均在96%左右。冲洗超滤浓缩后的超滤膜包和中空纤维柱1次,超滤系统中含有残留的病毒抗原,占病毒澄清液抗原含量的10%以上。2种超滤膜处理后的病毒浓缩液在2~8 ℃保存1周血凝滴度稳定,在-70 ℃保存1周后血凝滴度大幅度下降。

结论超滤膜包和中空纤维柱洗滤病毒澄清液的次数在5次及以上时,可获得较高病毒含量、低杂蛋白含量的病毒液。

超滤;浓缩;Madin Darby犬肾细胞;流感病毒B型;超滤膜包;中空纤维柱
ABSTRACT

ObjectiveTo study the effect of ultrafiltration concentration of influenza B virus liquid based on MDCK cell culture using ultrafiltration membrane package and hollow fiber column under different process parameters.

MethodsSix batches of influenza B virus clarified liquid based on MDCK cell culture were prepared. Ultrafiltration membrane packages and hollow fiber columns were used to make 2× concentrated influenza B virus clarified liquid, which was then washed and filtered. Hemagglutination titers of the virus concentrates were measured using chicken erythrocyte suspensions, protein content was determined by Lowry method 2 for the caculation of antigen recovery and miscellaneous protein removal rate, in order to investigate the effects of different washing times and types of ultrafiltration membranes on the above indices. Ultrafiltration concentration was carried out on the virus filtration solution that was washed and filtered 10 times to analyze the virus residue under different membrane cleaning times after ultrafiltration concentration using two types of ultrafiltration membranes. The stability of the virus concentrates stored at various temperatures was evaluated.

ResultsAfter filtration through the ultrafiltration membrane package and hollow fiber column, the hemagglutination titer of the virus filtrate remained stable, and the miscellaneous protein removal rate was relatively high at 5 times of filtration, reaching more than 90%. The antigen recovery rate of virus concentrates treated by hollow fiber column (61.95%) was slightly higher than that of ultrafiltration membrane package (49.91%), while the overall protein removal rates of the virus concentrates using both types of membranes were around 96%. After the ultrafiltration membrane package and hollow fiber column were washed once following ultrafiltration concentration, residual virus antigen in the ultrafiltration system accounted for over 10% of the antigen content of the virus clarification liquid. The virus concentrates processed with two types of membranes showed high stability after being stored at 2-8 ℃ for 1 week, while the hemagglutination titer dropped dramatically after being stored at -70 ℃ for 1 week.

ConclusionWhen the virus clarification liquid is washed and filtered using ultrafiltration membrane packages and hollow fiber columns 5 times and above, the virus solution obtained has high viral content and low heterogeneous protein content.

Ultrafiltration;Concentration;Madin Darby canine kidney cells;Influenza B virus;Ultrafiltration membrane package;Hollow fiber column
Wu Yixiao, Email: mocdef.3ab617080oaixiyuw
引用本文

吴熠潇,刘海东,朱绍荣. 基于MDCK细胞培养的B型流感病毒液的超滤浓缩工艺研究[J]. 国际生物制品学杂志,2025,48(01):26-31.

DOI:10.3760/cma.j.cn311962-20240730-00052

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
虽然应用MDCK细胞培养流感病毒、生产季节性流感病毒疫苗正成为继传统鸡胚培养之后的新选择 1 , 2,但MDCK细胞培养的流感病毒纯化工艺因宿主DNA残留风险高、杂蛋白去除率低、规模化生产成本高等因素而面临挑战 3。流感病毒抗原生产和纯化工艺的优化是提高季节性流感疫苗产量的重要方式。超滤浓缩是流感病毒纯化工艺中的关键步骤,处理量大、易于大规模产业化生产、生物活性损失小等特点使其成为病毒浓缩的主要方式 4。切向流过滤技术在狂犬病疫苗、流感疫苗等灭活病毒疫苗的下游工艺处理中应用广泛,使用该技术有望实现MDCK细胞培养的流感病毒纯度提高和合理产业化线性放大 5 , 6
本研究选用超滤膜包和中空纤维柱2种以切向流过滤技术为原理的超滤膜,超滤浓缩MDCK细胞培养的B型流感病毒澄清液,考察不同洗滤次数、超滤膜类型对病毒液的血凝滴度和杂蛋白去除效果的影响,同时分析不同膜清洗次数下病毒残留情况、不同保存温度下病毒浓缩液的保存稳定性,为基于MDCK细胞培养的流感病毒疫苗的超滤浓缩工艺提供理论依据。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Kim YH Hong KJ Kim H et al. Influenza vaccines:past,present,and future[J]. Rev Med Virol 2022321):e2243. DOI: 10.1002/rmv.2243 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
彭婷吴金妍. 动物细胞培养技术在流感疫苗研发中的应用进展[J]. 国际生物制品学杂志 2022455):277-282. DOI: 10.3760/cma.j.cn311962-20220110-00003 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Bissinger T Wu Y Marichal-Gallardo P et al. Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells[J]. Biotechnol Bioeng 202111810):3996-4013. DOI: 10.1002/bit.27876 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Carvalho S B Peixoto C Carrondo MJ T et al. Downstream processing for influenza vaccines and candidates:an update[J]. Biotechnol Bioeng 20211188):2845-2869. DOI: 10.1002/bit.27803 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
崔松奇张文芳刘兴刚. 狂犬病冻干灭活疫苗澄清与浓缩工艺的建立[J]. 畜禽业 2022336):14-16,20. DOI: 10.19567/j.cnki.1008-0414.2022.06.005 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
陈丽萍江兴华. 禽流感疫苗抗原浓缩工艺的研究[J]. 福建畜牧兽医 2017394):5-7.
返回引文位置Google Scholar
百度学术
万方数据
[7]
国家药典委员会. 中华人民共和国药典2020年版三部[M]. 北京中国医药科技出版社 2020106-108.
[8]
van Reis R Zydney A . Bioprocess membrane technology[J]. J Membr Sci 20072971/2):16-50. DOI: 10.1016/j.memsci.2007.02.045 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
罗丹. MDCK细胞基质流感疫苗纯化工艺研究[D]. 武汉武汉生物制品研究所 2020. DOI: 10.27382/d.cnki.gwszs.2020.000011 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Kalbfuss B Genzel Y Wolff M et al. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines[J]. Biotechnol Bioeng 2007971):73-85. DOI: 10.1002/bit.21139 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Nestola P Peixoto C Silva RR et al. Improved virus purification processes for vaccines and gene therapy[J]. Biotechnol Bioeng 20151125):843-857. DOI: 10.1002/bit.25545 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Asanzhanova NN Ryskeldinova SZ Chervyakova OV et al. Comparison of different methods of purification and concentration in production of influenza vaccine[J]. Bull Exp Biol Med 20171642):229-232. DOI: 10.1007/s10517-017-3964-y .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Tseng YF Weng TC Lai CC et al. A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography[J]. Vaccine 20183622):3146-3152. DOI: 10.1016/j.vaccine.2017.03.016 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
吴熠潇,Email: mocdef.3ab617080oaixiyuw
B

吴熠潇、刘海东:实验设计、研究实施、数据采集、数据分析、统计分析、论文撰写;朱绍荣:研究指导、论文修改、经费获取

C
感谢本次科研及论文写作过程中领导及研究室同事的指导和大力支持
D
所有作者均声明不存在利益冲突
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号